AAAAAA

   
Results: 1-21 |
Results: 21

Authors: Hicks, RJ Binns, D Stabin, MG
Citation: Rj. Hicks et al., Pattern of uptake and excretion of F-18-FDG in the lactating breast, J NUCL MED, 42(8), 2001, pp. 1238-1242

Authors: Stabin, MG
Citation: Mg. Stabin, Invited commentary - Investigation of patient release criteria, J NUCL MED, 42(6), 2001, pp. 916-916

Authors: Yoriyaz, H Stabin, MG dos Santos, A
Citation: H. Yoriyaz et al., Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry, J NUCL MED, 42(4), 2001, pp. 662-669

Authors: Stabin, MG Siegel, JA Sparks, RB Eckerman, KF Breit, HB
Citation: Mg. Stabin et al., Contribution to red marrow absorbed dose from total body activity: A correction to the MIRD method, J NUCL MED, 42(3), 2001, pp. 492-498

Authors: Stabin, MG Howell, RW Colas-Linhart, NC
Citation: Mg. Stabin et al., Modeling radiation dose and effects from internal emitters in nuclear medicine: From the whole body to individual cells, CELL MOL B, 47(3), 2001, pp. 535-543

Authors: Cremonesi, M Ferrari, M Chinol, M Bartolomei, M Stabin, MG Sacco, E Fiorenza, M Tosi, G Paganelli, G
Citation: M. Cremonesi et al., Dosimetry in radionuclide therapies with Y-90-conjugates: the IEO experience, Q J NUCL M, 44(4), 2000, pp. 325-332

Authors: Toohey, RE Stabin, MG Watson, EE
Citation: Re. Toohey et al., The AAPM/RSNA physics tutorial for residents - Internal radiation dosimetry: Principles and applications, RADIOGRAPHI, 20(2), 2000, pp. 533-546

Authors: Stabin, MG Breitz, HB
Citation: Mg. Stabin et Hb. Breitz, Breast milk excretion of radiopharmaceuticals: Mechanisms, findings, and radiation dosimetry, J NUCL MED, 41(5), 2000, pp. 863-873

Authors: Stabin, MG Konijnenberg, MW
Citation: Mg. Stabin et Mw. Konijnenberg, Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes, J NUCL MED, 41(1), 2000, pp. 149-160

Authors: Yoriyaz, H dos Santos, A Stabin, MG Cabezas, R
Citation: H. Yoriyaz et al., Absorbed fractions in a voxel-based phantom calculated with the MCNP-4B code, MED PHYS, 27(7), 2000, pp. 1555-1562

Authors: Stabin, MG Konijnenberg, M Knapp, FF Spencer, RH
Citation: Mg. Stabin et al., Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy, MED PHYS, 27(5), 2000, pp. 1086-1092

Authors: Traino, AC Di Martino, F Lazzeri, M Stabin, MG
Citation: Ac. Traino et al., Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism, PHYS MED BI, 45(1), 2000, pp. 121-129

Authors: Stabin, MG
Citation: Mg. Stabin, Internal dosimetry in the use of radiopharmaceuticals in therapy - Scienceat a crossroads?, CANC BIO R, 14(2), 1999, pp. 81-89

Authors: Behr, TM Sgouros, G Stabin, MG Behe, M Angerstein, C Blumenthal, RD Apostolidis, C Molinet, R Sharkey, RM Koch, L Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Studies on the red marrow dosimetry in radioimmunotherapy: An experimentalinvestigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters, CLIN CANC R, 5(10), 1999, pp. 3031S-3043S

Authors: Stabin, MG Tagesson, M Thomas, SR Ljungberg, M Strand, SE
Citation: Mg. Stabin et al., Radiation dosimetry in nuclear medicine, APPL RAD IS, 50(1), 1999, pp. 73-87

Authors: Cremonesi, M Ferrari, M Zoboli, S Chinol, M Stabin, MG Orsi, F Maecke, HR Jermann, E Robertson, C Fiorenza, M Tosi, G Paganelli, G
Citation: M. Cremonesi et al., Biokinetics and dosimetry in patients administered with In-111-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with Y-90-DOTATOC, EUR J NUCL, 26(8), 1999, pp. 877-886

Authors: Cremonesi, M Ferrari, M Chinol, M Stabin, MG Grana, C Prisco, G Robertson, C Tosi, G Paganelli, G
Citation: M. Cremonesi et al., Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients, EUR J NUCL, 26(2), 1999, pp. 110-120

Authors: Thomas, SR Stabin, MG Chen, CT Samaratunga, RC
Citation: Sr. Thomas et al., MIRD Pamphlet No. 14 revised: A dynamic urinary bladder model for radiation dose calculations, J NUCL MED, 40(4), 1999, pp. 102S-123S

Authors: Siegel, JA Thomas, SR Stubbs, JB Stabin, MG Hays, MT Koral, KF Robertson, JS Howell, RW Wessels, BW Fisher, DR Weber, DA Brill, AB
Citation: Ja. Siegel et al., MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates, J NUCL MED, 40(2), 1999, pp. 37S-61S

Authors: Behr, TM Behe, M Stabin, MG Wehrmann, E Apostolidis, C Molinet, R Strutz, F Fayyazi, A Wieland, E Gratz, S Koch, L Goldenberg, DM Becker, W
Citation: Tm. Behr et al., High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy and dose-limiting toxicity of Bi-213- versus Y-90-labeled CO17-1A Fab ' fragments in a human colonic cancer model, CANCER RES, 59(11), 1999, pp. 2635-2643

Authors: Stabin, MG Gelfand, MJ
Citation: Mg. Stabin et Mj. Gelfand, Dosimetry of pediatric nuclear medicine procedures, Q J NUCL M, 42(2), 1998, pp. 93-112
Risultati: 1-21 |